Standout Papers

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) ... 2007 2026 2013 2019 854
  1. Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest (2007)
    Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology

Immediate Impact

70 standout
Sub-graph 1 of 20

Citing Papers

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
2024 Standout
2 intermediate papers

Works of V. Picone being referenced

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007 Standout

Author Peers

Author Last Decade Papers Cites
V. Picone 806 302 213 423 8 894
W. Evangelista 830 293 235 419 7 919
S. Vitello 978 391 247 498 10 1.1k
F. Bertheault-Cvitkovic 835 245 254 400 15 999
Laura Fanchini 918 307 240 416 17 1.0k
Gianfranco Porcile 829 310 210 416 18 995
D Larregain-Fournier 917 253 261 316 8 1.1k
Carlos A. Garay 634 265 194 217 15 846
Marisa Di Seri 617 253 328 241 13 914
Claus Henning Köhne 753 268 164 211 18 890
Mario Kuperminc 809 260 194 155 10 954

All Works

Loading papers...

Rankless by CCL
2026